| Stage | CRMD | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102M | 100.00% | $24.4B | 100.00% | LLY ×239.35 |
| Gross profit | $77M | 75.66% | $20.5B | 83.88% | LLY +8.2pp |
| Operating income | $43M | 42.10% | $8.6B | 35.28% | CRMD +6.8pp |
| Pre-tax income | $39M | 38.00% | $8.4B | 34.46% | CRMD +3.5pp |
| Net income | $26M | 25.50% | $6.5B | 26.44% | LLY +0.9pp |
| Stage | CRMD | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $102M100.00% | $24.4B100.00% | LLY ×239.35 |
| Gross profit | 75.66%$77M | 83.88%$20.5B | LLY +8.2pp |
| Operating income | 42.10%$43M | 35.28%$8.6B | CRMD +6.8pp |
| Pre-tax income | 38.00%$39M | 34.46%$8.4B | CRMD +3.5pp |
| Net income |
| 25.50%$26M |
| 26.44%$6.5B |
| LLY +0.9pp |
None
No disclosed counterparties: CRMD.